Diagnosis of Neurosyphilis
Neurosyphilis is diagnosed by cerebrospinal fluid (CSF) examination showing a reactive CSF-VDRL combined with CSF white blood cell count >10 cells/µL, which together strongly support the diagnosis. 1, 2
When to Perform Lumbar Puncture
CSF examination should be performed in the following clinical scenarios:
- Neurologic or ocular symptoms or signs in any patient with syphilis 3, 1
- Active tertiary syphilis (cardiovascular or gummatous disease) 3
- Treatment failure of non-neurologic syphilis 3
- HIV-infected patients with late-latent syphilis or syphilis of unknown duration 3, 1
- HIV-infected patients with serum RPR ≥1:32 or CD4+ count <350 cells/µL, regardless of stage 3, 1
Some specialists recommend CSF examination for all HIV-infected persons with syphilis regardless of stage, though this remains controversial. 3
Diagnostic CSF Findings
The Gold Standard Combination
A reactive CSF-VDRL plus CSF WBC >10 cells/µL provides the strongest diagnostic support for neurosyphilis. 3, 1, 2
Individual CSF Parameters
CSF-VDRL:
- Highly specific but not sensitive - a reactive test establishes the diagnosis, but a nonreactive test does NOT exclude neurosyphilis 3, 1, 2
- This is the most specific test available for neurosyphilis 3
CSF White Blood Cell Count:
- Typically shows mild mononuclear pleocytosis of 10-200 cells/µL 3, 1, 2
- A count >10 cells/µL combined with reactive CSF-VDRL strongly supports the diagnosis 3, 1, 2
CSF Protein:
- Usually normal or mildly elevated 3, 1, 2
- The majority of specialists would NOT base the diagnosis solely on elevated CSF protein in the absence of reactive VDRL or elevated WBC 3, 2
CSF Treponemal Tests (e.g., CSF FTA-ABS)
- Sensitive but NOT specific - a nonreactive test excludes neurosyphilis, but a reactive test does NOT establish the diagnosis 3, 1, 2
- Useful primarily for ruling out neurosyphilis when negative 3, 1
Special Considerations in HIV-Infected Patients
HIV infection complicates the diagnosis because HIV itself can cause mild mononuclear CSF pleocytosis (5-15 cells/µL), particularly in patients with CD4+ counts >500 cells/µL. 3, 2
Critical decision point: If neurosyphilis cannot be excluded by a nonreactive CSF treponemal test in an HIV-infected patient, treat for neurosyphilis despite diagnostic uncertainty. 3, 1
The diagnostic threshold of >10 WBC/µL may need adjustment given baseline HIV-related pleocytosis. 2
Diagnostic Algorithm
Establish indication for lumbar puncture based on clinical presentation and HIV status 1
Obtain CSF for:
Interpret results:
Critical Pitfalls to Avoid
- Never diagnose neurosyphilis based solely on elevated CSF protein without reactive VDRL or elevated WBC 3, 2
- Do not exclude neurosyphilis based on a nonreactive CSF-VDRL alone - the test has limited sensitivity 3, 1, 2
- Blood contamination during lumbar puncture can cause false-positive CSF-VDRL results and must be considered 2
- PCR-based diagnostic methods are NOT currently recommended for neurosyphilis diagnosis 3
- Calculated indices (e.g., TPHA-index) are of limited value in establishing the diagnosis 3
Serum Testing Before CSF Examination
All patients should have positive serum syphilis serology (nontreponemal tests like VDRL or RPR confirmed by treponemal tests) before pursuing neurosyphilis diagnosis. 4
HIV-infected persons may have atypical responses to nontreponemal serologic tests (higher, lower, or delayed), but treponemal tests perform similarly in HIV-infected and uninfected patients. 3